Research article · 26 Jul 2022
Short communicationPublished 26 Mar 2022
METTL14 and its oncogenic roles in breast cancer cells
Abstract
Select any words in the title or abstract, or press this and choose a sentence.
Statement of the Problem: As an important m6A dynamic modification-related protein, METTL14 was reported not only played an oncogenic role but also functioned as a tumor suppressor gene. However, regulation of METTL14 across mRNA and copy number variation (CNV) remain elusive and its role in breast cancer cells has not been clarified clearly. Methods: Analysis of TCGA and cell experiments. Findings: There is a strong positive correlation between METTL14 mRNA and CNV among all subtypes of breast cancer, which indicated a regulation between METTL14 mRNA and CNV In addition, we found that knocking down METTL14 in breast cancer cells resulted in inhibition of cell growth and increased apoptosis in breast cancer cells. Conclusion & Significance: (1) METTL14 expressed differently in various subtypes of breast and there is a possible regulation existed between mRNA and CNV. (2) METTL14 knockdown lead to slower cell growth and increased cell apoptosis.
Keywords
Subjects
Oncology & CancerAsk about this article
Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.
More from this journal
The newest in Cancer Biology and Therapeutic Oncology.
Review article · 28 Jun 2022
Meddling of Viral Genome can Contribute Cancer by Cumulating the Global Burden
Conference abstract · 27 Mar 2022
Research progress of YTH domain protein family
Conferences in this field
Upcoming conferences in this field.
Follow
New articles from what you follow go into your email digest, once you agree to alert emails.
- JournalCancer Biology and Therapeutic Oncology
- SubjectOncology & Cancer
- BylineArticles whose byline prints “Yanfang Liu”
